enGene Therapeutics Inc. - Common Shares (ENGN)
CUSIP: 29286M105
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Shares
- Shares outstanding
- 67,348,192
- Total 13F shares
- 32,608,601
- Share change
- +951,063
- Total reported value
- $307,109,469
- Price per share
- $9.43
- Number of holders
- 30
- Value change
- -$7,912,013
- Number of buys
- 14
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 29286M105?
CUSIP 29286M105 identifies ENGN - enGene Therapeutics Inc. - Common Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29286M105:
Top shareholders of ENGN - enGene Therapeutics Inc. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FCPM III SERVICES B.V. |
13F
|
Company |
—
mixed-class rows
|
11,556,099
mixed-class rows
|
$162,057,638 | — | 31 Mar 2024 | |
| Fonds de solidarite des travailleurs et des travailleuses du Quebec |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,036,153
|
$45,542,295 | — | 18 Apr 2024 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
—
mixed-class rows
|
2,972,527
mixed-class rows
|
$44,378,003 | — | 31 Mar 2024 | |
| VR Adviser, LLC |
13F
|
Company |
3.8%
|
2,565,841
|
$43,491,005 | — | 31 Mar 2024 | |
| BVF INC/IL |
13F
|
Company |
—
mixed-class rows
|
3,196,439
mixed-class rows
|
$43,071,167 | — | 31 Mar 2024 | |
| Lumira Capital Investment Management Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,849,299
|
$38,492,990 | — | 20 Feb 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
3.3%
|
2,250,000
|
$38,137,500 | — | 31 Mar 2024 | |
| Commodore Capital LP |
13F
|
Company |
1.9%
|
1,250,000
|
$21,187,500 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.8%
|
1,200,000
|
$20,340,000 | — | 31 Mar 2024 | |
| Omega Fund Management, LLC |
13F
|
Company |
—
mixed-class rows
|
1,437,260
mixed-class rows
|
$20,120,947 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.5%
|
1,000,000
|
$17,095,000 | — | 31 Mar 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.5%
|
1,000,000
|
$16,950,000 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.5%
|
998,888
|
$16,931,152 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.2%
|
804,178
|
$13,630,817 | — | 31 Mar 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.2%
|
800,000
|
$13,560,000 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.2%
|
800,000
|
$13,560,000 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.2%
|
800,000
|
$13,560,000 | — | 31 Mar 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1.2%
|
800,000
|
$13,560,000 | — | 31 Mar 2024 | |
| Logos Global Management LP |
13F
|
Company |
1.2%
|
800,000
|
$12,882,000 | — | 31 Mar 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
1.1%
|
727,900
|
$12,337,905 | — | 31 Mar 2024 | |
| Vivo Capital, LLC |
13F
|
Company |
1%
|
678,705
|
$11,504,050 | — | 31 Mar 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.3%
|
200,000
|
$3,390,000 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.27%
|
182,586
|
$3,094,833 | — | 31 Mar 2024 | |
| Altitude Crest Partners Inc. |
13F
|
Company |
0.18%
|
120,289
|
$2,038,899 | — | 31 Mar 2024 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
—
mixed-class rows
|
162,616
mixed-class rows
|
$1,615,891 | — | 31 Mar 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
0.09%
|
62,422
|
$1,058,053 | — | 31 Mar 2024 | |
| Saba Capital Management, L.P. |
13F
|
Company |
—
class O/S missing
|
193,963
|
$1,008,608 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.08%
|
50,700
|
$859,365 | — | 31 Mar 2024 | |
| Calamos Advisors LLC |
13F
|
Company |
—
class O/S missing
|
150,000
|
$780,000 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
—
class O/S missing
|
104,622
|
$544,034 | — | 31 Mar 2024 | |
| Atalaya Capital Management LP |
13F
|
Company |
—
class O/S missing
|
66,666
|
$346,663 | — | 31 Mar 2024 | |
| TENOR CAPITAL MANAGEMENT Co., L.P. |
13F
|
Company |
—
class O/S missing
|
65,000
|
$338,000 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
16,126
|
$273,335 | — | 31 Mar 2024 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
—
class O/S missing
|
34,998
|
$181,989 | — | 31 Mar 2024 | |
| WHITEBOX ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
33,333
|
$173,332 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.01%
|
9,757
|
$165,381 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
7,915
|
$134,000 | — | 31 Mar 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
—
class O/S missing
|
23,570
|
$122,564 | — | 31 Mar 2024 | |
| CSS LLC/IL |
13F
|
Company |
—
class O/S missing
|
20,000
|
$104,000 | — | 31 Mar 2024 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
12,690
|
$65,988 | — | 31 Mar 2024 | |
| CLEAR STREET LLC |
13F
|
Company |
—
class O/S missing
|
5,000
|
$26,000 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
289
|
$4,899 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
14
|
$237 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
8
|
$136 | — | 31 Mar 2024 | |
| Forbion Growth Sponsor FEAC I B.V. |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
5,502,338
mixed-class rows
|
— | — | 31 Oct 2023 | |
| Forbion Capital Fund III Cooperatief U.A. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,894,735
|
— | — | 31 Oct 2023 | |
| Jason David Hanson |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
512,826
|
— | — | 31 Oct 2023 | |
| Richard P. Bryce |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
153,000
|
— | — | 30 Nov 2023 | |
| James C. Sullivan |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
118,509
|
— | — | 31 Oct 2023 | |
| BVF PARTNERS L P/IL |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
104,257
|
— | — | 31 Oct 2023 |
Institutional Holders of enGene Therapeutics Inc. - Common Shares (ENGN) as of Q2 2024
As of 30 Jun 2024,
enGene Therapeutics Inc. - Common Shares (ENGN) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,608,601 shares.
The largest 10 holders included
FCPM III SERVICES B.V., ADAGE CAPITAL PARTNERS GP, L.L.C., VR Adviser, LLC, Blue Owl Capital Holdings LP, BVF INC/IL, Deep Track Capital, LP, Logos Global Management LP, Omega Fund Management, LLC, JANUS HENDERSON GROUP PLC, and Cormorant Asset Management, LP.
This page lists
30
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
31
Q2 2024 holders
30
Holder diff
-1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.